We are an AI-science team committed to creating more modern and efficacious care models.
Safe, purpose built patient-facing technology that works exclusively under clinical supervision and high safety standards
Leveraging LLMs and cutting-edge science to develop a radically effective, clinically integrated, and scalable behavioral health solution
Led by previous biotech AI cofounder and team, and backed by world leaders in Psychology
Ormel, J., Hollon, S. D., Kessler, R. C., Cuijpers, P., & Monroe, S. M. (2022). More treatment but no less depression: The treatment-prevalence paradox. Clinical psychology review, 91, 102111.
Technologies like mRNA, complex antibodies, and cell therapies have improved nearly every aspect of human health in the last 30 years — but therapy and its clinical outcomes have not changed much. Jimini has built a scientifically rigorous, consumer-grade, LLM-augmented experience that is a radical improvement over traditional therapy.
AI and LLMs will impact every aspect of healthcare, including therapy. There are real risks if these technologies are developed without adequate safeguards or clinical integration. In response, Jimini has developed a narrow, specific, and well-validated approach to its AI development. Sage is not a general-purpose chatbot but rather supports the therapist and patient with specialized evidence-based approaches.
World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on truly the most complex parts of their job.
